Skip to main content
CDXSHealthcare

Codexis Inc. (CDXS) Insider Trading

In the last 90 days, 2 Codexis Inc. (CDXS) insiders reported no open-market purchases and 2 sales totaling $17,239. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 12, 2026Georgia ErbezSee RemarksSale6,335$1.36$8,619
Oct 12, 2026Alison MoorePresident and CEOSale6,335$1.36$8,619
Jun 11, 2026Vre Raymond DeDirectorSale2,605$2.37$6,174

Common questions

CDXS insider trading FAQ

Are CDXS insiders buying or selling?
Over the last 90 days, CDXS insiders were net sellers, reporting $0.00 of open-market purchases and $17,239 of sales.
When was the last CDXS insider purchase?
No open-market insider purchase of Codexis Inc. stock was reported in the last 90 days.
Where does CDXS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Codexis Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.